MK-0677 has been shown to increase the release and produce persistent plasma levels of multiple hormones including growth hormone and igf-1 level increases, but does not affect cortisol levels. Bumolen (Mk 0677, Mk 677,l 163191) is an oral active growth hormone secretion developed and developed by Merck (http://www.chemdrug.com/company/). This is a kind of piperidine compound. It can simulate the activity of growth hormone releasing peptide

If you are interested in our MK-0677 ,Please contact us by e-mail: sales@haihengpharma.com 

Custom SynthesisNews
MK-0677 has been shown to increase the release and produce persistent plasma levels of multiple hormones including growth hormone and igf-1 level increases, but does not affect cortisol levels. Bumolen (Mk 0677, Mk 677,l 163191) is an oral active growth hormone secretion developed and developed by Merck (http://www.chemdrug.com/company/). This...